Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,120 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Low toxicity of a conditioning with 8-Gy total body irradiation, fludarabine and cyclophosphamide as preparative regimen for allogeneic hematopoietic stem cell transplantation in pediatric hematological malignancies.
Yanagisawa R, Nakazawa Y, Sakashita K, Tanaka M, Shikama N, Kamijo T, Shiohara M, Koike K. Yanagisawa R, et al. Among authors: koike k. Pediatr Transplant. 2009 Sep;13(6):737-45. doi: 10.1111/j.1399-3046.2008.01065.x. Epub 2008 Dec 16. Pediatr Transplant. 2009. PMID: 19207225
Increased pretransplant QT dispersion as a risk factor for the development of cardiac complications during and after preparative conditioning for pediatric allogeneic hematopoietic stem cell transplantation.
Motoki N, Shimizu T, Akazawa Y, Saito S, Tanaka M, Yanagisawa R, Motoki H, Nakazawa Y, Sakashita K, Iwasaki Y, Shiohara M, Koike K. Motoki N, et al. Among authors: koike k. Pediatr Transplant. 2010 Dec;14(8):986-92. doi: 10.1111/j.1399-3046.2010.01389.x. Epub 2010 Sep 7. Pediatr Transplant. 2010. PMID: 21108706
Usefulness of allogeneic hematopoietic stem cell transplantation in first complete remission for pediatric blastic plasmacytoid dendritic cell neoplasm with skin involvement: a case report and review of literature.
Sakashita K, Saito S, Yanagisawa R, Tanaka M, Yoshikawa K, Hirabayashi K, Tsukahara K, Motobayashi M, Nakazawa Y, Koike K. Sakashita K, et al. Among authors: koike k. Pediatr Blood Cancer. 2013 Nov;60(11):E140-2. doi: 10.1002/pbc.24622. Epub 2013 Jun 20. Pediatr Blood Cancer. 2013. PMID: 23788509 Review.
Risk factors for diabetes mellitus and impaired glucose tolerance following allogeneic hematopoietic stem cell transplantation in pediatric patients with hematological malignancies.
Hirabayashi K, Nakazawa Y, Matsuura H, Hara Y, Kurata T, Hirabayashi K, Saito S, Yoshikawa K, Tanaka M, Yanagisawa R, Sakashita K, Koike K. Hirabayashi K, et al. Among authors: koike k. Int J Hematol. 2014 Apr;99(4):477-86. doi: 10.1007/s12185-014-1536-8. Epub 2014 Feb 21. Int J Hematol. 2014. PMID: 24557711
Safety and tolerability of allogeneic dendritic cell vaccination with induction of Wilms tumor 1-specific T cells in a pediatric donor and pediatric patient with relapsed leukemia: a case report and review of the literature.
Saito S, Yanagisawa R, Yoshikawa K, Higuchi Y, Koya T, Yoshizawa K, Tanaka M, Sakashita K, Kobayashi T, Kurata T, Hirabayashi K, Nakazawa Y, Shiohara M, Yonemitsu Y, Okamoto M, Sugiyama H, Koike K, Shimodaira S. Saito S, et al. Among authors: koike k. Cytotherapy. 2015 Mar;17(3):330-5. doi: 10.1016/j.jcyt.2014.10.003. Epub 2014 Dec 4. Cytotherapy. 2015. PMID: 25484308 Clinical Trial.
Loss of Mismatched HLA on the Leukemic Blasts of Patients With Relapsed Lymphoid Malignancies Following Bone Marrow Transplantation From Related Donors With HLA Class II Mismatches in the Graft Versus Host Direction.
Hirabayashi K, Kurata T, Horiuchi K, Saito S, Shigemura T, Tanaka M, Yanagisawa R, Matsuda K, Sakashita K, Koike K, Nakazawa Y. Hirabayashi K, et al. Among authors: koike k. Pediatr Blood Cancer. 2016 Apr;63(4):709-11. doi: 10.1002/pbc.25819. Epub 2015 Nov 6. Pediatr Blood Cancer. 2016. PMID: 26544669
3,120 results